Medinotec Income Statement (2022-2025) | MDNC

Income Statement Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025
Revenue & cost
Revenue (Quarter) 0.59M0.20M0.14M0.39M0.28M0.42M0.35M2.00M2.25M1.25M1.80M2.57M3.53M2.13M3.24M2.54M
Cost of Revenue (Quarter) 0.59M0.01M0.00M0.16M0.12M0.05M0.06M0.04M-1.21M0.02M0.97M0.05M-3.00M1.21M1.23M1.19M
Gross Profit (Quarter) 0.46M0.11M0.09M0.22M0.16M0.32M0.29M0.86M0.97M0.60M0.83M1.04M2.39M0.93M2.00M1.35M
Operating items
Research & Development (Quarter) 0.03M-0.03M0.02M0.01M-0.13M-0.00M0.01M0.00M-0.04M-0.01M0.00M0.07M-0.18M-0.05M0.07M0.01M
Selling, General & Administrative (Quarter) 0.60M-0.09M0.21M0.16M-1.11M-0.22M0.18M0.55M-2.62M-0.28M0.35M0.38M-2.40M-0.57M0.73M0.44M
Other Operating Expenses (Quarter) 0.01M-0.04M0.02M0.03M-0.20M-0.06M0.04M0.05M-0.30M-0.04M-0.75M-0.96M2.15M-0.03M-2.27M-1.24M
Operating Expenses (Quarter) 0.65M-0.16M0.26M0.20M-1.44M-0.28M0.23M0.61M-2.96M-0.33M-0.40M-0.51M-0.43M-0.65M-1.47M-0.79M
Operating Income (Quarter) -0.19M-0.05M-0.17M0.03M-0.04M0.04M0.06M0.26M0.25M0.27M0.44M0.53M1.96M0.28M0.53M0.55M
EBIT (Quarter) -0.19M-0.05M-0.17M0.03M-0.04M0.04M0.06M0.26M0.25M0.27M0.44M0.53M1.96M0.28M0.53M0.55M
Non-operating items
Interest & Investment Income (Quarter) 30.0062.0052.000.01M0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.01M-0.04M819.000.04M0.02M
Other Non Operating Income (Quarter) 0.00M0.01M0.01M0.01M0.03M0.03M-0.03M-0.01M0.01M0.00M0.01M-0.00M-0.01M0.02M0.01M-0.02M
Non Operating Income (Quarter) 0.00M-0.04M-0.05M-0.04M-0.18M-0.02M-0.03M-0.01M-0.85M0.00M0.01M-0.05M-0.01M-0.01M0.01M-0.02M
Net income details
EBT (Quarter) -0.19M-0.08M-0.22M-0.02M-0.07M0.02M-0.03M-0.43M0.19M0.21M0.41M0.48M1.92M0.26M0.54M0.54M
Tax Provisions (Quarter) -0.07M-0.04M0.00M0.01M0.06M-0.14M0.13M0.11M0.17M-1.16M-0.26M0.19M0.14M
Profit After Tax (Quarter) -0.17M-0.06M-0.19M-0.04M-0.06M0.02M-0.03M-0.49M0.10M0.09M0.28M0.31M1.48M0.11M0.35M0.40M
Income from Continuing Operations (Quarter) -0.12M-0.08M-0.22M0.02M-0.07M0.02M-0.04M-0.49M0.33M0.09M0.29M0.31M3.08M0.53M0.34M0.40M
Consolidated Net Income (Quarter) -0.12M-0.08M-0.22M0.02M-0.07M0.02M-0.04M-0.49M0.33M0.09M0.29M0.31M3.08M0.53M0.34M0.40M
Income towards Parent Company (Quarter) -0.12M-0.08M-0.22M0.02M-0.07M0.02M-0.04M-0.49M0.33M0.09M0.29M0.31M3.08M0.53M0.34M0.40M
Net Income towards Common Stockholders (Quarter) -0.12M-0.08M-0.22M0.02M-0.07M0.02M-0.04M-0.49M0.33M0.09M0.29M0.31M3.08M0.53M0.34M0.40M
Additional items
EPS (Basic) (Quarter) 0.01-0.01-0.010.02-0.030.000.00-0.040.010.010.020.030.120.010.030.03
EPS (Weighted Average and Diluted) (Quarter) 0.010.020.010.03
Shares Outstanding (Weighted Average) (Quarter) 10.00M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.73M11.76M11.76M
EBITDA (Quarter) -0.12M-0.05M-0.15M-0.05M-0.03M0.07M-0.06M-0.49M0.09M0.08M0.28M0.30M1.44M0.10M0.36M0.66M
Interest Expenses (Quarter) 0.01M-0.04M-0.05M0.06M-0.39M-0.07M-0.07M-0.07M-0.07M0.06M0.05M0.04M-0.32M0.03M0.04M0.01M
Tax Rate (Quarter) 34.39%230.87%9.69%-38.76%-14.68%-76.84%59.28%27.33%35.55%-60.09%-100.03%36.13%25.67%